Immigration experts warn the policy could make it easier for officers to deny visas based on their own judgment.

The indication was restricted to only patients with DMD who are 4 years of age and older with a confirmed mutation in the DMD gene; the indication for non-ambulatory patients with DMD was removed.

Tyruko ® (natalizumab-sztn), a biosimilar to Tysabri ® (natalizumab), has been made available by Sandoz, according to developer Polpharma Biologics.

The allergy develops after a bite from the Lone Star tick, which can make the body react to alpha-gal, a sugar found in beef, pork, lamb and other mammalian meats. Many people experience hives, nausea ...

The sNDA was supported by data from a 4 week MUSE study and a long-term open-label study in children aged 2 to 5 years.

Findings showed both zanidatamab treatment arms demonstrated statistically significant and clinically meaningful improvements in PFS vs the SOC arm.

Nonopioids are noninferior on days 2 and 3 and during the postoperative period; higher patient satisfaction reported with nonopioids.

HealthDay News — Commonly used noncancer medications, including proton pump inhibitors, are associated with poorer survival and adverse events for patients with breast cancer, according to a study ...

The outpatient procedure provides noninvasive magnetic stimulation through a cushioned helmet to induce electrical currents in localized regions of the prefrontal cortex.

Poherdy can be dispensed as a substitute for Perjeta without requiring a prescription change from a health care provider.

The phase 3 Librexia ACS trial evaluating the safety and efficacy of milvexian after a recent acute coronary syndrome has been discontinued.

Rates higher among those aged 18 to 21 years, and more than nine in 10 users found the advice somewhat or very helpful.